Accessing European Investment Capital for Healthcare and Lifescience Companies Panelists


  • Pietro Strada, Managing Director, Centerboard Partners Limited

    During the last 10 years Pietro has advised or acted as principal on over 20 completed financial transactions. Prior to founding Centerboard he was Strategy & Business Development Director with a division of Reed Elsevier. Pietro has successfully broadened Centerboard sector focus into the med-tech, advising leading companies that satisfy unmet medical needs with innovative or disruptive products. Formerly Pietro was a Principal at Broadview where for 5 years he covered the communications technologies and semiconductor sectors and led the execution of deals including cross-border mergers and acquisitions, fund-raisings and public takeovers. Prior to Broadview, Pietro was a consultant with Bain & Co. and earlier an electronic R&D engineer with OHB System and Italtel. He holds an MBA degree from INSEAD and an MS degree in electrical engineering from Politecnico di Milano. Speaks Italian, French and German.

    John Milad, Investor, NBGI Ventures

    John brings to NBGI Ventures an extensive track record in healthcare corporate finance and private equity. He joined from Insight Capital, which he founded to provide fundraising, strategy and M&A advisory services to life sciences companies and investors. John’s previous roles include Special Advisor to Atlas Venture, Interim CFO at Nitec Pharma, and Associate Director at Nomura International plc, where he was involved in a number of high profile transactions. John started his career as an investment banker at Lehman Brothers, followed by three years at Kirkland Investors. John holds a BA in Political Science from University of Chicago.

    Antoine Papiernik, Managing Partner, Sofinnova

    Antoine Papiernik is a Managing Partner at Sofinnova Partners in Paris. He invests in life sciences. He joined Sofinnova Partners in 1997, and was previously with CDC-Innovation, the venture arm of the Caisse des Dépôts group. Since joining Sofinnova Partners, Antoine has been an initial investor and active board member in companies like Actelion, Addex, Orexo and NovusPharma, which went public respectively on the Zürich stock exchange, the Stockholm stock exchange and the Milan Nuovo Mercato, in Cotherix (initially NASDAQ listed, then sold to Actelion) and CoreValve (sold to Medtronic). He has also invested in and is a board member of CoAxia, EOS, Fovea, Lectus, Movetis, SpineVision and Stentys. He has an MBA from the Wharton School of Business, University of Pennsylvania.

    Back to Trans-Atlantic Conference Programming

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!